Eli Lilly issues $4B in notes across four tranches, net proceeds ~$3.96B

ELI LILLY & Co

Issued $750M 5.000% notes due 2026, $1B 4.700% notes due 2033, $1.25B 4.875% notes due 2053, $1B 4.950% notes due 2063.
Net proceeds of approximately $3.96B after underwriting discounts and expenses.
Underwriters: J.P. Morgan, Credit Suisse, Goldman Sachs, Morgan Stanley.
Notes are senior unsecured obligations; redeemable at company's option upon certain events.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.